SunWay Biotech Co., LTD. (TPEX:1271)

SunWay Biotech Co., LTD. Revenue

SunWay Biotech Co., LTD. had revenue of 1.01B TWD in the half year ending June 30, 2026, with 108.31% growth. This brings the company's total for the last twelve months to 1.54B, up 61.34% year-over-year. In the year 2025, SunWay Biotech Co., LTD. had annual revenue of 993.30M with 2.38% growth. That makes SunWay Biotech Co., LTD. the 28,349th largest company in the world by revenue and 1,342nd in Taiwan.

• Revenue (ttm): 1.54B
• Revenue Growth: +61.34%
• P/S Ratio: 2.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.53B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 964.98M 97.1%
• Europe 12.10M 1.2%
• Other 10.73M 1.1%
• Americas 5.49M 0.6%

Fiscal year ended Dec 31, 2025 See the full SunWay Biotech Co., LTD. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	993.30M	23.12M	2.38%
Dec 31, 2024	970.18M	399.07M	69.88%
Dec 31, 2023	571.11M	145.76M	34.27%
Dec 31, 2022	425.35M	44.92M	11.81%
Dec 31, 2021	380.43M	65.96M	20.97%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 26, 2026

Data Sources Report a data error